MARC details
000 -LEADER |
fixed length control field |
03501cam a22004338i 4500 |
001 - CONTROL NUMBER |
control field |
21766327 |
003 - CONTROL NUMBER IDENTIFIER |
control field |
KENaKMTC |
005 - DATE AND TIME OF LATEST TRANSACTION |
control field |
20230201100501.0 |
006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS--GENERAL INFORMATION |
fixed length control field |
m |o d | |
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION |
fixed length control field |
cr ||||||||||| |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
fixed length control field |
201021s2021 flu ob 001 0 eng |
010 ## - LIBRARY OF CONGRESS CONTROL NUMBER |
LC control number |
2020047766 |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
International Standard Book Number |
9780853698357 |
Qualifying information |
(ebook) |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
Cancelled/invalid ISBN |
9780853698357 |
Qualifying information |
(hardcover) |
040 ## - CATALOGING SOURCE |
Original cataloging agency |
DLC |
Language of cataloging |
eng |
Transcribing agency |
KENKMTC |
Description conventions |
rda |
042 ## - AUTHENTICATION CODE |
Authentication code |
pcc |
050 00 - LIBRARY OF CONGRESS CALL NUMBER |
Classification number |
RM301.25 |
Item number |
2009 |
060 00 - NATIONAL LIBRARY OF MEDICINE CALL NUMBER |
Classification number |
QV 241 |
082 00 - DEWEY DECIMAL CLASSIFICATION NUMBER |
Classification number |
615.1/9 |
Edition number |
23 |
245 00 - TITLE STATEMENT |
Title |
Applied pharmaceutical practice and nutraceuticals : |
Remainder of title |
natural product developments / |
Statement of responsibility, etc |
edited by Debarshi Kar Mahapatra, Cristóbal Noé Aguilar, A.K. Haghi. |
250 ## - EDITION STATEMENT |
Edition statement |
First edition. |
260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) |
Place of publication, distribution, etc |
London |
Name of publisher, distributor, etc |
Pharmaceutical Press |
Date of publication, distribution, etc |
2009 |
263 ## - PROJECTED PUBLICATION DATE |
Projected publication date |
2102 |
300 ## - PHYSICAL DESCRIPTION |
Extent |
1 online resource |
504 ## - BIBLIOGRAPHY, ETC. NOTE |
Bibliography, etc |
Includes bibliographical references and index. |
520 ## - SUMMARY, ETC. |
Summary, etc |
"Applied Pharmaceutical Practice and Nutraceuticals: Natural Product Developments showcases how pharmaceutical and nutraceutical compounds from natural products can be used to cure or prevent diseases. The chapters explore the connections between agrochemicals and pharmaceuticals and the use of plants and plant products in the formulation and development of new pharmaceuticals and nutraceuticals. The pharmaceutical industry recognizes the shift to the use of natural products while also considering the serious concerns that have arisen regarding the claimed efficacy, quality, and safety of these products. Chapters cover: The emerging perspectives of natural chalcone-based nitric acid inhibitors The pharmacological properties of Emblicanin-A and Emblicanin-B constituents found in Phyllanthus emblica The pathophysiology and various herbal drugs used for treating helminthiasis (or worm infections) and their pharmacological activities Natural medicines that can be employed as diuretics The utilization, safety, and therapeutic perspectives of medicinal plant for treating psoriasis and skin diseases The role of nutrients and cofactors, dietary adjustments and gut anomalies, probiotics and prebiotics, phytochemicals, and ecological factors for evaluating the condition of proof in nutraceutical-based disease management practices Beer as a major source of compounds associated with health benefits, which could possibly decrease the risks of cardiovascular disease The role of the media as an important source of health information to help with personal medical decisions, specifically regarding cancer The composition of Artemisia herba-alba and Origanum majorana essential oils is analyzed, and their antibacterial and antifungal activity How medicinal plants and herbs combined with some kinds of alcohol develop healing, stimulating, and aphrodisiac effects while others can cause adverse effects and allergies"-- |
650 12 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name as entry element |
Biological Products |
General subdivision |
pharmacology |
650 12 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name as entry element |
Biological Products |
General subdivision |
therapeutic use |
650 22 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name as entry element |
Dietary Supplements |
650 22 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name as entry element |
Drug Discovery |
General subdivision |
methods |
650 22 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name as entry element |
Drug Therapy |
700 1# - ADDED ENTRY--PERSONAL NAME |
Personal name |
Mahapatra, Debarshi Kar, |
Relator term |
editor. |
700 1# - ADDED ENTRY--PERSONAL NAME |
Personal name |
Aguilar, Cristóbal Noé, |
Relator term |
editor. |
700 1# - ADDED ENTRY--PERSONAL NAME |
Personal name |
Haghi, A. K., |
Relator term |
editor. |
776 08 - ADDITIONAL PHYSICAL FORM ENTRY |
Display text |
Print version: |
Title |
Applied pharmaceutical practice and nutraceuticals |
Edition |
First edition. |
Place, publisher, and date of publication |
Palm Bay, FL : Apple Academic Press, [2021] |
International Standard Book Number |
9781771889247 |
Record control number |
(DLC) 2020047765 |
906 ## - LOCAL DATA ELEMENT F, LDF (RLIN) |
a |
7 |
b |
cbc |
c |
orignew |
d |
1 |
e |
ecip |
f |
20 |
g |
y-gencatlg |
942 ## - ADDED ENTRY ELEMENTS (KOHA) |
Source of classification or shelving scheme |
Library of Congress Classification |
Koha item type |
Books |
Edition |
1st Edition |
Classification part |
RM301.25 |
Item part |
2009 |
Intials |
KM |